These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 11979069)
1. Possible mechanisms of hypopigmentation in lichen sclerosus. Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069 [TBL] [Abstract][Full Text] [Related]
2. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Singh ZN; Tretiakova MS; Shea CR; Petronic-Rosic VM Mod Pathol; 2006 Sep; 19(9):1255-60. PubMed ID: 16778827 [TBL] [Abstract][Full Text] [Related]
3. Histopathological differences between vitiligo and lichen sclerosus et atrophicus using quantitative immunohistochemical analysis. Park YJ; Lee H; Park HS; Kim YC Front Med (Lausanne); 2023; 10():1205909. PubMed ID: 37521337 [TBL] [Abstract][Full Text] [Related]
4. Hypopigmentation in burns is associated with alterations in the architecture of the skin and the dendricity of the melanocytes. Dutta S; Panda S; Singh P; Tawde S; Mishra M; Andhale V; Athavale A; Keswani SM Burns; 2020 Jun; 46(4):906-917. PubMed ID: 31685389 [TBL] [Abstract][Full Text] [Related]
5. Histopathologic features in vitiligo. Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112 [TBL] [Abstract][Full Text] [Related]
6. Vitiligoid lichen sclerosus: a reappraisal. Attili VR; Attili SK Indian J Dermatol Venereol Leprol; 2008; 74(2):118-21. PubMed ID: 18388368 [TBL] [Abstract][Full Text] [Related]
7. Lichen Sclerosus on the Sites of Striae Distensae and a Surgical Scar in a Patient with Coexistent Morphea. Baykal C; Kobaner GB; Copur S; Buyukbabani N Acta Dermatovenerol Croat; 2019 Mar; 27(1):44-46. PubMed ID: 31032793 [TBL] [Abstract][Full Text] [Related]
8. Vulvar nevi, lichen sclerosus et atrophicus, and vitiligo. Carlson JA; Mihm MC Arch Dermatol; 1997 Oct; 133(10):1314-6. PubMed ID: 9382579 [No Abstract] [Full Text] [Related]
9. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker. Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772 [TBL] [Abstract][Full Text] [Related]
10. Histopathology and immunohistochemistry of depigmented lesions in lupus erythematosus. França AF; de Souza EM J Cutan Pathol; 2010 May; 37(5):559-64. PubMed ID: 19807822 [TBL] [Abstract][Full Text] [Related]
11. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311 [TBL] [Abstract][Full Text] [Related]
12. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study. Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912 [TBL] [Abstract][Full Text] [Related]
13. Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus. Fung MA; LeBoit PE Am J Surg Pathol; 1998 Apr; 22(4):473-8. PubMed ID: 9537476 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214 [TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathologic characteristics of nevus depigmentosus. Kim SK; Kang HY; Lee ES; Kim YC J Am Acad Dermatol; 2006 Sep; 55(3):423-8. PubMed ID: 16908347 [TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ. Kim J; Taube JM; McCalmont TH; Glusac EJ J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920 [TBL] [Abstract][Full Text] [Related]
17. Autoimmune etiology of generalized vitiligo. Le Poole IC; Luiten RM Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889 [TBL] [Abstract][Full Text] [Related]
18. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo. Teulings HE; Willemsen KJ; Glykofridis I; Krebbers G; Komen L; Kroon MW; Kemp EH; Wolkerstorfer A; van der Veen JP; Luiten RM; Tjin EP Pigment Cell Melanoma Res; 2014 Nov; 27(6):1086-96. PubMed ID: 25043574 [TBL] [Abstract][Full Text] [Related]